Senior insider sale
President, R&D & CMO at MAZE THERAPEUTICS, INC. — senior position signals high conviction
$1.59M
57.58K shares
What this filing means
BERNSTEIN HAROLD plans to sell 57.58K shares of MAZE THERAPEUTICS, INC. valued at approximately $1.59M. Form 144 is a notice of intent to sell restricted or control securities — not a mandatory transaction. This filing provides advance warning of potential selling pressure.
Filed: 9/2/2026ACC: 0002050172-26-000031
Officer· President, R&D & CMO
Since Mar 2026
57.58K
Shares to sell
$1.59M
Approx. market value
10.69K
Acquired (3 months)
1
Planned
3 completed
Securities Acquired — Last 3 Months1
Restricted Stock Unit Vesting
Compensation
9/1/2026
10.69KTotal acquired10.69K
| Acquisition Date | Type | Amount Acquired | Gift |
|---|---|---|---|
9/1/2026 | Restricted Stock Unit Vesting Compensation | 10.69K | — |
| Total | 10.69K | ||
Planned & Completed Dispositions4
Completed
—Completed
Units to sell
16.14K
Market value
$425.5K
9/1/2026
—Completed
Units to sell
16.14K
Market value
$445.6K
8/13/2026
—Completed
Units to sell
14.61K
Market value
$436.9K
7/1/2026
Planned — Approximate Date
NASDAQPlanned
Units to sell
10.69K
Market value
$283.5K
9/2/2026
Total
Units
57.58K
Value
$1.59M
| Date | Units to Sell | Approx. Market Value | Exchange | Status |
|---|---|---|---|---|
| Completed | ||||
9/1/2026 | 16.14K | $425.5K | — | Completed |
8/13/2026 | 16.14K | $445.6K | — | Completed |
7/1/2026 | 14.61K | $436.9K | — | Completed |
| Planned — Approximate Date | ||||
9/2/2026 | 10.69K | $283.5K | NASDAQ | Planned |
| Total | 57.58K | $1.59M | ||